Osaic Holdings’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Osaic Holdings’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,600	Closed	-$1.05K	–	7569
2023 Q3	$1.05K	Sell	3,600 -15,150	-81%	-$7.99K	﹤0.01%	6808
2023 Q2	$9.12K	Sell	18,750 -160	-0.8%	-$103	﹤0.01%	6018
2023 Q1	$17K	Sell	18,910 -1,000	-5%	-$1.26K	﹤0.01%	5667
2022 Q4	$24K	Buy	19,910 +1,650	+9%	+$2.41K	﹤0.01%	5460
2022 Q3	$29K	Buy	18,260 +1,950	+12%	+$4.67K	﹤0.01%	5333
2022 Q2	$43K	Buy	+16,310	New	+$54K	﹤0.01%	5077

Osaic Holdings's CMRA Position: Q4 2023 in Review

Osaic Holdings sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 3,600 shares — an estimated $1.05K sold.

Osaic Holdings first reported a position in CMRA in Q2 2022 and held it in 6 quarters. The position peaked at $43K in Q2 2022. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

Osaic Holdings reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 3,600 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $1.05K.
Osaic Holdings first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Osaic Holdings's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $43K in Q2 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.